8770
R. Csuk et al. / Tetrahedron Letters 47 (2006) 8769–8770
Whereas the oxidation of 2 with TEMPO19 (2,2,6,6-
tetramethyl-piperidin-1-oxyl)/NaClO2/NaOCl at 35 °C
furnished 92% of the aldehyde betulinal (3),20 the reac-
tion of 2 with 4-acetamido-TEMPO/NaClO2/NaOCl at
50 °C gave betulinic acid (1) in an 86% isolated yield.21
16. Kim, D. S. H. L.; Chen, Z.; Van Tuyen, N.; Pezzuto, J.
M.; Qiu, S.; Lu, Z.-Z. Synth. Commun. 1997, 27, 1607–
1612.
17. Pichette, A.; Liu, H.; Roy, C.; Tanguay, S.; Simard, F.;
Lavoie, S. Synth. Commun. 2004, 34, 3925–3937.
18. Menard, H.; Cirtiu, C. M.; Lalancette, J.-M.; Ruest, L.;
Kaljaca Z. PCT 2006 1063464A1; Chem. Abs. 2006,
604456.
19. Zhao, M.; Li, J.; Mano, E.; Song, Z.; Tschaen, D. M.;
Grabowski, E. J. J.; Reider, P. J. J. Org. Chem. 1999, 64,
2564–2566.
20. Bhattacharyya, J.; Kokpol, U.; Miles, D. H. Phytochem-
istry 1976, 15, 431–433.
Preliminary work done in our laboratories indicates that
this procedure for the synthesis of 1 can be scaled up to
obtain larger amounts of 1 in a very convenient way.
The main advantages of this approach include the use
of inexpensive starting material and reagents as well as
the simplicity of the route (Scheme 1).
21. Synthesis of betulinal (3): To a 35 °C warm stirred mixture
of dichloromethane (80 ml) and phosphate buffer (0.67 M,
pH 6.8, 43 ml) containing betulin 2 (5.0 g, 11.3 mmol),
TEMPO (125 mg, 0.8 mmol) and Bu4NBrÆH2O (180 mg,
0.55 mmol) aq solutions of NaClO2 (25%, 6.8 ml,
22.6 mmol) and NaOCl (12%, 115 ll, 0.25 mmol) were
slowly added within 120 min. Additional aq NaOCl
(17.8 ml, 34.6 mmol) and Bu4NBrÆH2O (180 mg,
0.55 mmol) was then slowly added. After completion of
the reaction (as monitored by tlc) and cooling to room
temperature, water (85 ml) was added and the pH value
adjusted to 8 by the addition of aq NaOH (2 N, 10.5 ml).
The reaction mixture was poured in ice-cold water (60 ml),
the aq phase was extracted (methyl-tert-butyl-ether, 60 ml)
and the combined organic phases were washed (water,
brine), dried (Na2SO4), and the solvents were evaporated
in vacuo to afford the crude aldehyde that was subjected to
recrystallization from methanol to afford pure 3 (4.58 g,
92%) as white crystals. Mp 189–191 °C, [a]D +18.4 (c, 0.4,
CHCl3)20 (Lit.: mp 183–187;22 192–193;23 [a]D +18 (c, 0.4,
CHCl3), [a]D +19 (CHCl3)23); 1H and 13C NMR data24 as
reported. Synthesis of betulinic acid (1): To a 50 °C warm
mixture of butyl acetate (80 ml) and aq phosphate buffer
(0.67 M, pH 7.6, 43 ml) containing 2 (5.0 g, 11.3 mmol), 4-
acetamido-TEMPO25 (171 mg, 0.8 mmol), Bu4NBrÆH2O
(180 mg, 0.55 mmol) aq solutions of NaClO2 (25%,
6.76 ml, 22.6 mmol) and NaOCl (12%, 115 ll, 0.25 mmol)
were slowly added within 120 min. Stirring at this
temperature was continued and some additional NaOCl
(12%, 10 ml, 19.44 mmol) was slowly added until tlc
showed the reaction to be complete. After cooling to room
temperature, water (85 ml) was added and the pH adjusted
to 8 by the addition of aq NaOH (2 N, 0.5 ml). After
extraction with butylacetate (300 ml), the phases were
separated, the organic phase was washed (water, brine)
and dried (Na2SO4). After evaporation of the solvents,
crude 1 was recrystallized from methanol to afford pure 1
(4.43 g, 86%, >98% by HPLC). Mp 310–313 °C, [a]D +9
(c, 0.36 CHCl3 (Lit.: mp 316–31826 [a]D +5 (CHCl3)27);
ESI-MS: m/z = 456 [MÀH]À.
Acknowledgements
This research was supported by the VFF Universita¨t
Halle-Wittenberg. We are grateful to Dr. D. Stro¨hl for
NMR measurements and to Dr. R. Kluge for numerous
ESI-MS spectra.
References and notes
1. Mukherjee, R.; Kumar, V.; Srivastava, S. K.; Agarwal, S.
K.; Burman, A. C. Anti-cancer Agents Med. Chem. 2006,
6, 271–279.
2. Tolstikova, T. G.; Sorokina, I. V.; Tolstikov, G. A.;
Tolstikov, A. G.; Flekhter, O. B. Russ. J. Bioorg. Chem.
2006, 32, 37–49.
3. Bi, Y.; Xu, J.; Wu, X. Zhongguo Xinyao Zazhi 2005, 14,
23–26.
4. Yogeeswari, P.; Sriram, D. Curr. Med. Chem. 2005, 12,
657–666.
5. Aiken, C.; Chen, C. H. Trends Mol. Med. 2005, 11, 31–
36.
6. Pisha, E.; Chai, H.; Lee, I. S.; Chagwedera, T. E.;
Farnsworth, N. R.; Cordell, G. A.; Beecher, C. W. W.;
Fong, H. H. S.; Kinghorn, A. D.; Brown, D. M.; Wari, M.
C.; Wall, M. E.; Hieken, T. J.; Das Gupta, T. K.; Pezzuto,
J. M. Nat. Med. 1995, 1, 1046–1051.
7. Galgon, T.; Ho¨ke, D.; Dra¨ger, B. Phytochem. Anal. 1999,
10, 187–190.
8. Ramadoss, S.; Siddiqui, M. J. M.; PCT WO 2001064709
A1 (07.09.2001); Chem. Abs. 2001, 661451.
9. Dra¨ger, B.; Neubert, R.; Galgon, T.; Wohlrab W.
Ger. Offen DE 19713768 (8.10.1998); Chem. Abs. 1998,
689287.
10. Ender, C.; Sauter, M. DE 10204278 C1 (07.08.2003);
Chem. Abs. 2003, 607453.
11. Levdanskij, V. A.; Polezhaeva, N. I.; Kuznetsov, B. N.
RU 2269541 (10.02.2006); Chem. Abs. 2006, 126094.
12. Kogai, T. I.; Kuznetsov, B. N. RU 2271364 (10.03.2006);
Chem. Abs. 2006, 218258.
13. Baltina, E. I.; Flekhter, O. B.; Nigmatullina, L. R.;
Boreko, E. I.; Pavlova, N. I.; Nikolaeva, S. N.; Savinova,
O. V.; Tolstikov, G. A. Bioorg. Med. Chem. Lett. 2003, 13,
3549–3552.
14. Ashavina, O. Y.; Flekhter, O. B.; Galin, F. Z.; Kabal’-
nova, N. N.; Baltina, L. A.; Tolstikov, G. A. Chem. Nat.
Compd. 2003, 39, 207–211.
22. Ziegler, H. L.; Franzyk, H.; Sairafianpour, M.; Tabataba,
M.; Tehrani, M. D.; Bagherzadeh, K.; Ha¨gerstrand, H.;
Stark, D.; Jaroszewski, J. W. Bioorg. Med. Chem. 2004,
12, 119–127.
23. Monaco, P.; Previtera, L. J. Nat. Prod. 1984, 47, 673.
24. Macias, F. A.; Simonet, A. M.; Esteban, M. D. Phyto-
chemistry 1994, 36, 1369–1679.
25. Merbough, N.; Bobbitt, J. M.; Bruckner, C. J. Carbohydr.
Chem. 2002, 21, 65–67.
26. Tiwar, K. P.; Choudhary, R. N. Polish J. Chem. 1979, 53,
551–552.
27. Sundararamaiah, T.; Ramraj, S. K.; Rao, K. L.; Vimala-
bai, V. J. Indian Chem. Soc. 1976, 53, 638.
15. Krasutsky, P. A. US Patent 2002016482 A1 (02.07.2002);
Chem. Abs. 2002, 107929.